<DOC>
	<DOCNO>NCT00579020</DOCNO>
	<brief_summary>The purpose study determine whether Moxidex ophthalmic solution safe effective treat marginal corneal infiltrates .</brief_summary>
	<brief_title>A Phase II Study Moxidex Ophthalmic Solution Treatment Marginal Corneal Infiltrates</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Diagnosis marginal corneal infiltrates size equal le 1.5mm diameter , mild , moderate severe bulbar conjunctival injection least one eye . Other protocoldefined inclusion criterion may apply . Age related . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>cornea</keyword>
	<keyword>inflammation</keyword>
	<keyword>blepharitis</keyword>
	<keyword>lid infection</keyword>
</DOC>